| CIN/LLPIN/FCRN | U72200KA2011FTC058276 |
| ROC Name | ROC Bangalore |
| Company Type | Company |
| Company Category | Company limited by shares |
| Activity Description | |
| Active Compliance | - |
| Date of Inc | 20 April, 2011 |
| Date of AGM | 10 July, 2013 |
| Date of B/S | 31 March, 2013 |
| Company Status | Amalgamated |
| CIRP | - |
| Address other than R/o | - |
| Authorise Capital | 10,00,000 |
| Paid up capital | 10,00,000 |
| u**********@a********.com | |
| Listing Status | Not Listed |
| filling status | - |
| Pan | - |
| Registered Address | Prestige Shantiniketan, Tower B, 15th Floor, Whitefield,, Bangalore, Bangalore, Karnataka - 560048, India |
| Sr No | DIN | Name | Designation | Begin Date |
|---|---|---|---|---|
| 1 | 02215843 | RAJEEV CHOPRA | Director | 10 July, 2013 |
| 2 | 05273528 | KAUSHAL MAHESH MODY | Director | 10 July, 2013 |
The CIN (Corporate Identification Number) for OCTAGON CLINICAL RESEARCH SOLUTIONS INDI A PRIVATE LIMITED is U72200KA2011FTC058276.
OCTAGON CLINICAL RESEARCH SOLUTIONS INDI A PRIVATE LIMITED is registered with ROC Bangalore.
OCTAGON CLINICAL RESEARCH SOLUTIONS INDI A PRIVATE LIMITED is a Company limited by shares.
The main activity of OCTAGON CLINICAL RESEARCH SOLUTIONS INDI A PRIVATE LIMITED is .
OCTAGON CLINICAL RESEARCH SOLUTIONS INDI A PRIVATE LIMITED was incorporated on 20 April, 2011.
OCTAGON CLINICAL RESEARCH SOLUTIONS INDI A PRIVATE LIMITED is currently Amalgamated.
The authorized capital of OCTAGON CLINICAL RESEARCH SOLUTIONS INDI A PRIVATE LIMITED is ₹10,00,000.
The paid-up capital of OCTAGON CLINICAL RESEARCH SOLUTIONS INDI A PRIVATE LIMITED is ₹10,00,000.
No, OCTAGON CLINICAL RESEARCH SOLUTIONS INDI A PRIVATE LIMITED is not listed on stock exchange.
The registered address of OCTAGON CLINICAL RESEARCH SOLUTIONS INDI A PRIVATE LIMITED is Prestige Shantiniketan, Tower B, 15th Floor, Whitefield,, Bangalore, Bangalore, Karnataka - 560048, India
There are 2 directors in OCTAGON CLINICAL RESEARCH SOLUTIONS INDI A PRIVATE LIMITED. RAJEEV CHOPRA, and KAUSHAL MAHESH MODY.